|
|
|
|
| LEADER |
00000cam a22000007i 4500 |
| 001 |
SCIDIR_on1363836412 |
| 003 |
OCoLC |
| 005 |
20231120010722.0 |
| 006 |
m o d | |
| 007 |
cr ||||||||||| |
| 008 |
221031s2023 enk fo 001 0 eng d |
| 040 |
|
|
|a UKAHL
|b eng
|e rda
|c UKAHL
|d EBLCP
|d OPELS
|d N$T
|d YDX
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1358902294
|
| 020 |
|
|
|a 0323953263
|q (e-book)
|
| 020 |
|
|
|a 9780323953269
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323953252
|q (pbk.)
|
| 020 |
|
|
|z 0323953255
|
| 035 |
|
|
|a (OCoLC)1363836412
|z (OCoLC)1358902294
|
| 050 |
|
4 |
|a RS199.5
|
| 082 |
0 |
4 |
|a 615.19
|2 23/eng/20230215
|
| 245 |
0 |
0 |
|a Nanotechnology for drug delivery and pharmaceuticals /
|c edited by Ravindra Pratap Singh, Kshitij R.B. Singh, Jay Singh, Charles Oluwaseun Adetunji.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Front Cover -- Nanotechnology for Drug Delivery and Pharmaceuticals -- Copyright Page -- Dedication -- Contents -- List of contributors -- About the editors -- Preface -- Acknowledgments -- 1 Targeted drug delivery -- 1 Introduction to drug-delivery techniques based on nanotechnological approaches -- Introduction -- Synthesis of nanocarriers and nanomedicines for targeted drug delivery -- Biological synthesis -- Physiochemical synthesis -- Utility of nanocarriers -- Tumors -- Neurodegenerative diseases -- Utility of nanomedicines -- Targeted drug delivery
|
| 505 |
8 |
|
|a Strategies of targeted drug delivery system -- Pros of nano-based targeted drug delivery -- Toxicity of nanomaterials used for targeted drug delivery applications -- Conclusion -- References -- 2 Methods of fabricating various nanocarriers for targeted drug delivery -- Introduction -- Various nanocarriers for drug delivery -- Fabrication methods/formulation method of nanocarriers -- Conclusion and prospects -- References -- 3 Biologically synthesized nanocarriers for targeted drug delivery applications -- Introduction -- Biogenic nanocarriers employed in drug delivery
|
| 505 |
8 |
|
|a Plant-based virus nanoparticles and virus-like particles -- Bacteria and bacterial spores -- Extracellular vesicles -- Cyclodextrins -- Biomimetic nanocarriers -- Polymer-based nanocarriers -- Physicochemical properties of nanocarriers for their use in targeted drug delivery systems -- Plant protein-based nanocarriers for targeted drug delivery system -- Smart nanocarriers in clinical interventions and translation for targeted therapies or disease treatments -- Conclusions and future prospects -- References -- 4 Nanomedicine and nanocarriers for cancer treatment -- Introduction
|
| 505 |
8 |
|
|a Nanotechnology in cancer therapy -- Nanomedicines for cancer treatment -- Nanotechnology to nanomedicine -- Emerging vaccine nanotechnology -- Enhancing drug delivery to the tumor -- Principles involved in the development of nanomedicine -- Opportunities: advanced functionalities -- Tumor targeting via enhanced permeability and retention -- Passive targeting or physical targeting -- Active targeting -- Stimuli-responsive systems/triggered release -- Internally responsive drug delivery -- Thermo-responsive delivery -- pH-responsive delivery -- Enzyme-responsive delivery
|
| 505 |
8 |
|
|a Inflammation-responsive delivery -- Redox-responsive delivery -- Externally responsive drug delivery -- Photo-responsive delivery -- Thermo-responsive delivery -- Magnetic response delivery -- Multifunctionality/theranostics -- Antibody-mediated targeting -- Antiangiogenesis -- Nanomedicine in cancer treatment -- Viral nanoparticles for cancer therapy -- Organic nanocarriers for cancer therapy -- Drug conjugates -- Lipid-based nanocarriers -- Liposomes -- Polymer-based nanocarriers -- Polymeric micelles -- Inorganic nanoparticles for cancer therapy -- Porous inorganic nanomaterials
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Drug delivery systems
|x Technological innovations.
|
| 650 |
|
0 |
|a Nanoparticles.
|
| 650 |
|
2 |
|a Nanoparticles
|0 (DNLM)D053758
|
| 650 |
|
6 |
|a Syst�emes d'administration de m�edicaments
|0 (CaQQLa)000260397
|x Innovations.
|0 (CaQQLa)201-0379286
|
| 650 |
|
6 |
|a Nanoparticules.
|0 (CaQQLa)201-0262530
|
| 650 |
|
7 |
|a Nanoparticles
|2 fast
|0 (OCoLC)fst01032624
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Pratap Singh, Ravindra,
|e editor.
|
| 700 |
1 |
|
|a Singh, Kshitij R. B.,
|e editor.
|
| 700 |
1 |
|
|a Singh, Jay,
|e editor.
|
| 700 |
1 |
|
|a Adetunji, Charles Oluwaseun,
|e editor.
|
| 776 |
0 |
8 |
|i ebook version :
|z 9780323953269
|
| 776 |
0 |
8 |
|c Original
|z 0323953255
|z 9780323953252
|w (OCoLC)1321786705
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323953252
|z Texto completo
|
